✦ LIBER ✦

Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma

✍ Scribed by Paolo Macor; Nelly Mezzaroba; Luca De Maso; Chiara Garrovo; Stefania Biffi; Daniele Sblattero; Roberto Marzari; Francesco Tedesco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of human bispecific antibodi

✍ P. Macor; E. Secco; N. Mezzaroba; L. De Maso; P. Durigutto; T. Gaiotto; C. Garro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Characterization of a humanized anti-CD2

✍ Lan Wu; Chong Wang; Dapeng Zhang; Xunming Zhang; Weizhu Qian; Lei Zhao; Hao Wang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 781 KB

Neutralizing human antibodies against CD

✍ P. Macor; E. Piovan; S. Zorzet; C. Tripodo; R. Marzari; A. Amadori; F. Tedesco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

The anti-CD20 antibody rituximab augment

✍ David J. Flavell; Sarah L. Warnes; Christine J. Bryson; Sarah A. Field; Armorel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Treatment of a patient with a nodal peri

✍ H. Hagberg; M. Pettersson; T. Bjerner; G. Enblad 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 48 KB

Combination of rituximab with blinatumom

✍ Sandrine d’Argouges; Sandra Wissing; Christian Brandl; Nadja Prang; Ralf Lutterb 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 815 KB